The Trump administration appears poised to extend a temporary, Covid-era rule allowing health providers to prescribe certain controlled substances, like ADHD medications and treatments for opioid addiction, via telemedicine.

Under the current rules, providers can initiate prescriptions for drugs like Ritalin or Adderall for ADHD, or buprenorphine for opioid use disorder, without first examining the patient in-person.

The extension would mark the fourth time that the federal government has re-upped the flexibilities, enacted by the Drug Enforcement Administration during March 2020 as the Covid-19 pandemic accelerated, without reaching a permanent decision on how telemedicine prescribing of controlled substances will be regulated moving forward.

A posting on a White House budget website,

See Full Page